On the consistency of the continual reassessment method with multiple toxicity constraints
From MaRDI portal
Publication:499432
DOI10.1016/j.jspi.2015.03.001zbMath1322.62307OpenAlexW1969076593MaRDI QIDQ499432
Publication date: 30 September 2015
Published in: Journal of Statistical Planning and Inference (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jspi.2015.03.001
consistencymodel misspecificationdose finding trialmultiplicative modelordinal toxicitysequential design
Asymptotic properties of parametric estimators (62F12) Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05)
Related Items
Cites Work
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach
- Optimal Bayesian-feasible dose escalation for cancer phase I trials
- A Simple Technique to Evaluate Model Sensitivity in the Continual Reassessment Method
- Design and Analysis of Phase I Clinical Trials
- Continual reassessment method with multiple toxicity constraints
- Consistency of continual reassessment method under model misspecification
- Concavity of the Log Likelihood
- A Random Walk Rule for Phase I Clinical Trials
- Designs foe phase i cancer clinical trials with differentiation of graded toxicity
- The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Quasi‐Likelihood Approach
- Dose-Finding Based on Multiple Toxicities in a Soft Tissue Sarcoma Trial